% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • insidetrack22 insidetrack22 Feb 15, 2013 9:46 AM Flag

    Don't sell your IMGN shares prior to T-DM1 approval

    Money makers will tell you IMGN is worthless and try to steal your shares. To sell now would be a mistake. Hold on to your shares to force shorts and money makers to pay even more when T-DM1 is approved. Here are the positive catalyst that will make IMGN jump this year: (1) FDA approval of T-DM1 (2) Interim results of North trial (3) Interinm results of T-DM1 trial for 1st line use (4) European approval. These are teh catalyst we know for sure. Other potential catalyst (1) Possible acquisition (2) New partnerships and milestones (3) Suprisingly strong revenue from T-DM1 sales (4) T-DM1 regulatory submission in asia

5.8501-0.3199(-5.18%)2:31 PMEDT